Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-CABG thromboprophylaxis: enoxaparin versus unfractionated heparin haemostatic analysis
2015-000702-19Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- May 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of enoxaparin and heparin in venous thromboembolism (VTE) and postoperative hemorrhage (2 arms), sponsored by Rigshospitalet. Primary endpoint: TEG reaction time. Started May 2015; status: completed.
02
Drugs
enoxaparinheparin
03
Conditions
venous thromboembolism (VTE)postoperative hemorrhage
Beyond the preview
Go deeper on 2015-000702-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000702-19.